The Novartis site sits on the edge of the Humber Estuary |
A NEW 35-acre wetland bird reserve is set to be created on the South Bank of the Humber.
It will be developed on land around the site of the 220-acre Novartis chemical works, on the outskirts of Grimsby, when the multinational pharmaceutical company bids farewell at the end of this year.
To be known as Novartis Ings, it will be a sister site to the Cress Marsh project in nearby Stallingborough.
This new reserve will benefit from being adjacent to the Pyewipe mudflats - one of the UK’s most important sites for feeding and roosting waders of numerous species including curlew, golden plover, lapwing, dunlin, redshank and avocet.
Like Cress Marsh, it will be a “mitigation site” provided to compensate for wildlife habitat likely to be lost to make way for future industrial development nearby.
Unfortunately, because of shortage of staffing and management resources, Novartis Ings is unlikely to be open to the public in the same way as, say, the RSPB reserves at Frampton and Freiston, both near Boston, but bird-monitoring and recording will be undertaken by specialists.
It is understood that the reserve will be managed by North East Lincolnshire Council.
The site covers some 220 acres in total |
As this sign indicates, Novartis is already mindful of its responsibilities to wildlife |
Redshank - one of many wading bird species set to benefit |
No comments:
Post a Comment